HIP Surgery - Hemodynamic Optimization Project
- Conditions
- Redo Hip Surgery
- Interventions
- Device: Stroke volume monitoring
- Registration Number
- NCT01753050
- Lead Sponsor
- Charite University, Berlin, Germany
- Brief Summary
Several studies have demonstrated that goal-directed fluid therapy during high- risk-surgery reduces morbidity and length of hospital stay. This quality improvement is design to evaluate the implementation of an intraoperative goal-directed therapy, using a pulse contour analysis monitor to optimize the stroke volume, in patients undergoing redo-hip-surgery. The primary combined endpoints will be the incidence of postoperative complications and the secondary endpoints will be the decrease of hospital length of stay, length of ICU stay and hospital postoperative mortality. We amended another 130 patients getting crystalloid fluids in the hemodynamic optimization protocol.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 390
- patients undergoing redo hip surgery
- age above 18 years
- signed informed consent
- urgent or emergency surgery
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Hemodynamic optimization Stroke volume monitoring Hemodynamic optimization by stroke volume monitoring
- Primary Outcome Measures
Name Time Method postoperative complications 30days
- Secondary Outcome Measures
Name Time Method length of hospital and ICU stay 30days
Trial Locations
- Locations (1)
Department of Anesthesiology and Intensive Care Medicine Campus Charité Mitte / Campus Virchow-Klinikum
🇩🇪Berlin, Germany